154 related articles for article (PubMed ID: 25375122)
1. Eribulin mesylate targets human telomerase reverse transcriptase in ovarian cancer cells.
Yamaguchi S; Maida Y; Yasukawa M; Kato T; Yoshida M; Masutomi K
PLoS One; 2014; 9(11):e112438. PubMed ID: 25375122
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
3. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467
[TBL] [Abstract][Full Text] [Related]
4. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
[TBL] [Abstract][Full Text] [Related]
5. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells.
Meng E; Taylor B; Ray A; Shevde LA; Rocconi RP
Gynecol Oncol; 2012 Mar; 124(3):598-605. PubMed ID: 22115853
[TBL] [Abstract][Full Text] [Related]
7. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
Luo Y; Yi Y; Yao Z
Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma.
Buttitta F; Pellegrini C; Marchetti A; Gadducci A; Cosio S; Felicioni L; Barassi F; Salvatore S; Martella C; Coggi G; Bosari S
J Clin Oncol; 2003 Apr; 21(7):1320-5. PubMed ID: 12663721
[TBL] [Abstract][Full Text] [Related]
9. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
10. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway.
Wang Z; Kyo S; Takakura M; Tanaka M; Yatabe N; Maida Y; Fujiwara M; Hayakawa J; Ohmichi M; Koike K; Inoue M
Cancer Res; 2000 Oct; 60(19):5376-81. PubMed ID: 11034074
[TBL] [Abstract][Full Text] [Related]
11. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
13. Human telomerase reverse transcriptase (hTERT): a target molecule for the treatment of cisplatin-resistant tumors.
Park YP; Kim KD; Kang SH; Yoon DY; Park JW; Kim JW; Lee HG
Korean J Lab Med; 2008 Dec; 28(6):430-7. PubMed ID: 19127107
[TBL] [Abstract][Full Text] [Related]
14. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling reveals epithelial mesenchymal transition (EMT) genes can selectively differentiate eribulin sensitive breast cancer cells.
Dezső Z; Oestreicher J; Weaver A; Santiago S; Agoulnik S; Chow J; Oda Y; Funahashi Y
PLoS One; 2014; 9(8):e106131. PubMed ID: 25171249
[TBL] [Abstract][Full Text] [Related]
16. Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts.
Takahashi M; Miki S; Fujimoto K; Fukuoka K; Matsushita Y; Maida Y; Yasukawa M; Hayashi M; Shinkyo R; Kikuchi K; Mukasa A; Nishikawa R; Tamura K; Narita Y; Hamada A; Masutomi K; Ichimura K
Cancer Sci; 2019 Jul; 110(7):2247-2257. PubMed ID: 31099446
[TBL] [Abstract][Full Text] [Related]
17. The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells.
Sundin T; Peffley DM; Gauthier D; Hentosh P
Biochimie; 2012 Dec; 94(12):2639-48. PubMed ID: 22902867
[TBL] [Abstract][Full Text] [Related]
18. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
[TBL] [Abstract][Full Text] [Related]
19. Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate.
Bräutigam K; Mitzlaff K; Uebel L; Köster F; Polack S; Pervan M; Steinert G; Rody A; Liedtke C
Anticancer Res; 2016 Jun; 36(6):2759-66. PubMed ID: 27272786
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
